Sequoia Financial Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
Sequoia Financial Advisors's CRL Position: Q2 2026 in Review
Sequoia Financial Advisors reduced its Charles River Laboratories (CRL) stake by 20% in Q2 2026, selling an estimated $123K and leaving 2,805 shares worth $636K. The position accounts for ﹤0.01% of the portfolio, ranked #1183.
Sequoia Financial Advisors first reported a position in CRL in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.67M in Q1 2024. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Sequoia Financial Advisors held 2,805 shares of Charles River Laboratories worth $636K as of Q2 2026.
- Sequoia Financial Advisors sold 688 Charles River Laboratories shares in Q2 2026, an estimated $123K.
- Charles River Laboratories made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #1183 holding.
- Sequoia Financial Advisors first reported a position in Charles River Laboratories in Q4 2022 and has held it in 15 quarters since.
- Sequoia Financial Advisors's Charles River Laboratories position peaked at $3.67M in Q1 2024.
- 565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.